• Ethical

Actellion

read more

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of small-molecule drugs as innovative treatments to serve high unmet medical needs. The company has its corporate headquarters in Allschwil/Basel, Switzerland where it was founded in 1997.

The company has proven its ability to discover new com¬pounds and to rapidly move them from research through development to commercialization. In particular, Actelion scientists were among the first to work in the field of en¬dothelin receptor antagonists, leading to its lead product, Tracleer®.

Actelion has over 30 operative affiliates around the world including the United States, Canada, Brazil, Australia, Japan, Switzerland and a number of EU countries. These subsidiaries provide or will provide distribution, sales and marketing services.

RELATED PROJECTS

You might be also interested in...

Interested in joining our list of clients?

CONTACT US